European markets breathed a sigh of relief after the on-again, off-again global trade war inspired by President Donald Trump was put on paus |
|
|
What You Need to Know Today | |
|
|
|
|
European drugmakers tanked along with the rest of the pharmaceutical industry after Trump vowed to cut US prescription costs. The president said he’s planning an executive order mandating that Americans pay comparable prices to people in other countries. The announcement meant that AstraZeneca lost its crown as the UK’s most valuable listed company. Novo Nordisk and Sanofi also fell. The US is big business because Americans spend more on prescription drugs than any other country in the world. | |
|
Saudi Arabia expects a Trump dividend after helping to lower oil prices. Crown Prince Mohammed bin Salman is preparing to welcome Trump back with a grand display of pageantry as the two look to monetize their relationship. But the transaction might not go the way Trump had envisaged. With a slump in oil prices of the kingdom’s own making, the Saudi financial dynamic has shifted: the big spender abroad is in urgent need of money at home. A poster promoting Vision 2030 in Riyadh, in 2022 Photographer: TAMIR KALIFA/NYTNS | |
|
European borrowing costs will fall more than expected this year, according to economists we surveyed. The European Central Bank is now expected to lower interest rates below 2% as inflation undershoots heading into 2026. There’s a similar picture in Switzerland, where rates are seen falling to zero after less than three years in positive territory. | |
|
There’s a $1 trillion opportunity in helping people adapt to climate change. That was the conclusion of a new London Stock Exchange study, which found that much being generated in total revenue from 2,100 companies providing products and services helping to adjust to life on a hotter planet. Underscoring the rising value of novel climate technologies, Towerbrook Capital Partners is preparing to sell an Austrian bio-refinery for $500 million that’s helping farmers adapt to drought. | |
|
Still mongering over fish, or is something deeper at play heading into the summit between the EU and UK? Britain and the EU are still trying to resolve disagreements over fisheries just a week before Prime Minister Keir Starmer plans to announce a major reset in post-Brexit relations. While the focus on what swims below still waters perpetually triggers emotions on both sides of the channel, other topics on the agenda could potentially be more consequential. They include migration, trade and defence. Even barring a deal over fishing rights at next week’s meeting in London, change is on the way for consumers who enjoy eating the fruit of the sea. Eating With the Ecosystem is trying to introduce ‘climate winners’ such as blue crab to restaurants in the New England region. Photographer: PIERO CRUCIATTI/AFP | |
What You’ll Need to Know Tomorrow | |
|
|
Yoël Zaoui, the co-founder of boutique investment bank Zaoui & Co., has relocated to Milan as the London-based firm seeks to strengthen its ties with Italian and French corporates. The 64-year-old veteran banker is the latest financier to leave the UK as British lawmakers are curbing perks for living there. We’re told that Zaoui—a French and British national—has opted to move to Italy where some of the firm’s key clients including Assicurazioni Generali SpA are based. | |
|
Enjoying Evening Briefing? Check out these newsletters: - Markets Daily for what’s moving in stocks, bonds, FX and commodities
- Breaking News Alerts for the biggest stories from around the world, delivered to your inbox as they happen
| |